AUTHOR=Teng Chubei , Yang Qi , Xiong Zujian , Ye Ningrong , Li Xuejun 

TITLE=Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma

JOURNAL=Frontiers in Surgery

VOLUME=8

YEAR=2021

URL=https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2021.764329

DOI=10.3389/fsurg.2021.764329

ISSN=2296-875X

ABSTRACT=<p><bold>Background:</bold> Skull base chordoma is a rare tumor with low-grade malignancy and a high recurrence rate, the factors affecting the prognosis of patients need to be further studied. For that, we investigated prognostic factors of skull base chordoma through the database of the Surveillance, Epidemiology, and End Results (SEER) program, and validated in an independent data set from the Xiangya Hospital.</p><p><bold>Methods:</bold> Six hundred and forty-three patients diagnosed with skull base chordoma were obtained from the SEER database (606 patients) and the Xiangya Hospital (37 patients). Categorical variables were selected by Chi-square test with a statistical difference. Survival curves were constructed by Kaplan–Meier analysis and compared by log-rank test. Univariate and multivariate Cox regression analyses were used to explore the prognostic factors. Propensity score matching (PSM) analysis was undertaken to reduce the substantial bias between gross total resection (GTR) and subtotal resection (STR) groups. Furthermore, clinical data of 37 patients from the Xiangya Hospital were used as validation cohorts to check the survival impacts of the extent of resection and adjuvant radiotherapy on prognosis.</p><p><bold>Results:</bold> We found that age at diagnosis, primary site, disease stage, surgical treatment, and tumor size was significantly associated with the prognosis of skull base chordoma. PSM analysis revealed that there was no significant difference in the OS between GTR and STR (<italic>p</italic> = 0.157). Independent data set from the Xiangya Hospital proved no statistical difference in OS between GTR and STR groups (<italic>p</italic> = 0.16), but the GTR group was superior to the STR group for progression-free survival (PFS) (<italic>p</italic> = 0.048). Postoperative radiotherapy does not improve OS (<italic>p</italic> = 0.28), but it can prolong PFS (<italic>p</italic> = 0.0037). Nomograms predicting 5- and 10-year OS and DSS were constructed based on statistically significant factors identified by multivariate Cox analysis. Age, primary site, tumor size, surgical treatment, and disease stage were included as prognostic predictors in the nomograms with good performance.</p><p><bold>Conclusions:</bold> We identified age, tumor size, surgery, primary site, and tumor stage as main factors affecting the prognosis of the skull base chordoma. Resection of the tumor as much as possible while ensuring safety, combined with postoperative radiotherapy may be the optimum treatment for skull base chordoma.</p>